» Articles » PMID: 23319557

Influenza-induced Inflammation Drives Pneumococcal Otitis Media

Abstract

Influenza A virus (IAV) predisposes individuals to secondary infections with the bacterium Streptococcus pneumoniae (the pneumococcus). Infections may manifest as pneumonia, sepsis, meningitis, or otitis media (OM). It remains controversial as to whether secondary pneumococcal disease is due to the induction of an aberrant immune response or IAV-induced immunosuppression. Moreover, as the majority of studies have been performed in the context of pneumococcal pneumonia, it remains unclear how far these findings can be extrapolated to other pneumococcal disease phenotypes such as OM. Here, we used an infant mouse model, human middle ear epithelial cells, and a series of reverse-engineered influenza viruses to investigate how IAV promotes bacterial OM. Our data suggest that the influenza virus HA facilitates disease by inducing a proinflammatory response in the middle ear cavity in a replication-dependent manner. Importantly, our findings suggest that it is the inflammatory response to IAV infection that mediates pneumococcal replication. This study thus provides the first evidence that inflammation drives pneumococcal replication in the middle ear cavity, which may have important implications for the treatment of pneumococcal OM.

Citing Articles

A Trivalent Live Vaccine Elicits Cross-Species Protection Against Acute Otitis Media in a Murine Model.

Echlin H, Iverson A, McKnight A, Rosch J Vaccines (Basel). 2025; 12(12.

PMID: 39772092 PMC: 11728825. DOI: 10.3390/vaccines12121432.


Evidence for vagal sensory neural involvement in influenza pathogenesis and disease.

Verzele N, Chua B, Short K, Moe A, Edwards I, Bielefeldt-Ohmann H PLoS Pathog. 2024; 20(4):e1011635.

PMID: 38626267 PMC: 11051609. DOI: 10.1371/journal.ppat.1011635.


An infant mouse model of influenza-driven nontypeable colonization and acute otitis media suitable for preclinical testing of novel therapies.

Landwehr K, Granland C, Martinovich K, Scott N, Seppanen E, Berry L Infect Immun. 2024; 92(5):e0045323.

PMID: 38602405 PMC: 11075455. DOI: 10.1128/iai.00453-23.


Innate Immunity in the Middle Ear Mucosa.

Massa H, Spann K, Cripps A Front Cell Infect Microbiol. 2021; 11:764772.

PMID: 34778109 PMC: 8586084. DOI: 10.3389/fcimb.2021.764772.


Type I Diabetes Mellitus Increases the Cardiovascular Complications of Influenza Virus Infection.

Sinclair J, Bloxham C, Chiu H, Chew K, Russell J, Yoshikawa Y Front Cell Infect Microbiol. 2021; 11:714440.

PMID: 34595130 PMC: 8476859. DOI: 10.3389/fcimb.2021.714440.


References
1.
Cripps A, Otczyk D, Kyd J . Bacterial otitis media: a vaccine preventable disease?. Vaccine. 2005; 23(17-18):2304-10. DOI: 10.1016/j.vaccine.2005.01.023. View

2.
Chun Y, Moon S, Lee H, Webster P, Brackmann D, Rhim J . Immortalization of normal adult human middle ear epithelial cells using a retrovirus containing the E6/E7 genes of human papillomavirus type 16. Ann Otol Rhinol Laryngol. 2002; 111(6):507-17. DOI: 10.1177/000348940211100606. View

3.
McCullers J, Karlstrom A, Iverson A, Loeffler J, Fischetti V . Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog. 2007; 3(3):e28. PMC: 1829406. DOI: 10.1371/journal.ppat.0030028. View

4.
Reading P, Morey L, Crouch E, Anders E . Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol. 1997; 71(11):8204-12. PMC: 192277. DOI: 10.1128/JVI.71.11.8204-8212.1997. View

5.
Zhou H, Haber M, Ray S, Farley M, Panozzo C, Klugman K . Invasive pneumococcal pneumonia and respiratory virus co-infections. Emerg Infect Dis. 2012; 18(2):294-7. PMC: 3310442. DOI: 10.3201/eid1802.102025. View